Cargando…

Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging

BACKGROUND: Near-infrared quantum dots (NIR QDs) are a new class of fluorescent labels with excellent bioimaging features, such as high fluorescence intensity, good fluorescence stability, sufficient electron density, and strong tissue-penetrating ability. For all such features, NIR QDs have great p...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Jlenia, Riolo, Giulia, Gentile, Mariangela, Bernini, Andrea, Paccagnini, Eugenio, Falciani, Chiara, Lozzi, Luisa, Scali, Silvia, Depau, Lorenzo, Pini, Alessandro, Lupetti, Pietro, Bracci, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834876/
https://www.ncbi.nlm.nih.gov/pubmed/29501065
http://dx.doi.org/10.1186/s12951-018-0346-1
_version_ 1783303727191425024
author Brunetti, Jlenia
Riolo, Giulia
Gentile, Mariangela
Bernini, Andrea
Paccagnini, Eugenio
Falciani, Chiara
Lozzi, Luisa
Scali, Silvia
Depau, Lorenzo
Pini, Alessandro
Lupetti, Pietro
Bracci, Luisa
author_facet Brunetti, Jlenia
Riolo, Giulia
Gentile, Mariangela
Bernini, Andrea
Paccagnini, Eugenio
Falciani, Chiara
Lozzi, Luisa
Scali, Silvia
Depau, Lorenzo
Pini, Alessandro
Lupetti, Pietro
Bracci, Luisa
author_sort Brunetti, Jlenia
collection PubMed
description BACKGROUND: Near-infrared quantum dots (NIR QDs) are a new class of fluorescent labels with excellent bioimaging features, such as high fluorescence intensity, good fluorescence stability, sufficient electron density, and strong tissue-penetrating ability. For all such features, NIR QDs have great potential for early cancer diagnosis, in vivo tumor imaging and high resolution electron microscopy studies on cancer cells. RESULTS: In the present study we constructed NIR QDs functionalized with the NT4 cancer-selective tetrabranched peptides (NT4-QDs). We observed specific uptake of NT4-QDs in human cancer cells in in vitro experiments and a much higher selective accumulation and retention of targeted QDs at the tumor site, compared to not targeted QDs, in a colon cancer mouse model. CONCLUSIONS: NIR QDs labelled with the tetrabranched NT4 peptide have very promising performance for selective addressing of tumor cells in vitro and in vivo, proving rising features of NT4-QDs as theranostics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12951-018-0346-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5834876
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58348762018-03-05 Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging Brunetti, Jlenia Riolo, Giulia Gentile, Mariangela Bernini, Andrea Paccagnini, Eugenio Falciani, Chiara Lozzi, Luisa Scali, Silvia Depau, Lorenzo Pini, Alessandro Lupetti, Pietro Bracci, Luisa J Nanobiotechnology Research BACKGROUND: Near-infrared quantum dots (NIR QDs) are a new class of fluorescent labels with excellent bioimaging features, such as high fluorescence intensity, good fluorescence stability, sufficient electron density, and strong tissue-penetrating ability. For all such features, NIR QDs have great potential for early cancer diagnosis, in vivo tumor imaging and high resolution electron microscopy studies on cancer cells. RESULTS: In the present study we constructed NIR QDs functionalized with the NT4 cancer-selective tetrabranched peptides (NT4-QDs). We observed specific uptake of NT4-QDs in human cancer cells in in vitro experiments and a much higher selective accumulation and retention of targeted QDs at the tumor site, compared to not targeted QDs, in a colon cancer mouse model. CONCLUSIONS: NIR QDs labelled with the tetrabranched NT4 peptide have very promising performance for selective addressing of tumor cells in vitro and in vivo, proving rising features of NT4-QDs as theranostics. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12951-018-0346-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-03 /pmc/articles/PMC5834876/ /pubmed/29501065 http://dx.doi.org/10.1186/s12951-018-0346-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Brunetti, Jlenia
Riolo, Giulia
Gentile, Mariangela
Bernini, Andrea
Paccagnini, Eugenio
Falciani, Chiara
Lozzi, Luisa
Scali, Silvia
Depau, Lorenzo
Pini, Alessandro
Lupetti, Pietro
Bracci, Luisa
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging
title Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging
title_full Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging
title_fullStr Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging
title_full_unstemmed Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging
title_short Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging
title_sort near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834876/
https://www.ncbi.nlm.nih.gov/pubmed/29501065
http://dx.doi.org/10.1186/s12951-018-0346-1
work_keys_str_mv AT brunettijlenia nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT riologiulia nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT gentilemariangela nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT berniniandrea nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT paccagninieugenio nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT falcianichiara nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT lozziluisa nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT scalisilvia nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT depaulorenzo nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT pinialessandro nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT lupettipietro nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging
AT bracciluisa nearinfraredquantumdotslabelledwithatumorselectivetetrabranchedpeptideforinvivoimaging